Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Cash from Financing Activities (2024 - 2025)

Historic Cash from Financing Activities for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $2.7 million.

  • Beta Bionics' Cash from Financing Activities rose 32559.52% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.7 million, marking a year-over-year change of. This contributed to the annual value of $55.6 million for FY2024, which is 4495.14% down from last year.
  • Latest data reveals that Beta Bionics reported Cash from Financing Activities of $2.7 million as of Q3 2025, which was up 32559.52% from $42000.0 recorded in Q2 2025.
  • Beta Bionics' 5-year Cash from Financing Activities high stood at $211.1 million for Q1 2025, and its period low was -$1.2 million during Q3 2024.